A physiological ligand of positive selection is recognized as a weak agonist

被引:7
作者
Berg, RE
Irion, S
Kattman, S
Princiotta, MF
Staerz, UD
机构
[1] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80220 USA
[3] Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80220 USA
关键词
D O I
10.4049/jimmunol.165.8.4209
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Positive selection is a process that ensures that peripheral T cells express TCR that are self-MHC restricted. This process occurs in the thymus and requires both self-MHC and self-peptides. We have recently established a TCR transgenic (TCRtrans+) mouse model using the C10.4 TCR restricted to the MHC class Tb molecule, H2-M3, Having defined H2-M3 as the positively selecting MHC molecule, the severely limited number of H2-M3 binding peptides allowed us to characterize a mitochondrial NADH dehydrogenase subunit 1-derived 9-mer peptide as the physiological ligand of positive selection. Here, we demonstrate that the NADH dehydrogenase subunit 1 self-peptide is seen by mature C10.4 TCRtrans+ T cells as a weak agonist and induces positive selection at a defined concentration range. We also found that the full-length cognate peptide, a strong agonist for mature C10.4 TCRtrans+ T cells, initiated positive selection, albeit at significantly lower concentrations. At increased peptide concentrations, and thus increased epitope densities, either peptide only induced the development of partially functional T cells. We conclude that successful positive selection only proceeded at a defined, yet fairly narrow window of avidity.
引用
收藏
页码:4209 / 4216
页数:8
相关论文
共 61 条
[1]   A DIFFERENTIAL-AVIDITY MODEL FOR T-CELL SELECTION [J].
ASHTONRICKARDT, PG ;
TONEGAWA, S .
IMMUNOLOGY TODAY, 1994, 15 (08) :362-366
[2]   PEPTIDE CONTRIBUTES TO THE SPECIFICITY OF POSITIVE SELECTION OF CD8+ T-CELLS IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
VANKAER, L ;
SCHUMACHER, TNM ;
PLOEGH, HL ;
TONEGAWA, S .
CELL, 1993, 73 (05) :1041-1049
[3]   EVIDENCE FOR A DIFFERENTIAL AVIDITY MODEL OF T-CELL SELECTION IN THE THYMUS [J].
ASHTONRICKARDT, PG ;
BANDEIRA, A ;
DELANEY, JR ;
VANKAER, L ;
PIRCHER, HP ;
ZINKERNAGEL, RM ;
TONEGAWA, S .
CELL, 1994, 76 (04) :651-663
[4]   Requirement for diverse, low-abundance peptides in positive selection of T cells [J].
Barton, GM ;
Rudensky, AY .
SCIENCE, 1999, 283 (5398) :67-70
[5]   THE EFFECTS OF MHC GENE DOSAGE AND ALLELIC VARIATION ON T-CELL RECEPTOR SELECTION [J].
BERG, LJ ;
FRANK, GD ;
DAVIS, MM .
CELL, 1990, 60 (06) :1043-1053
[6]   Positive selection of an H2-M3 restricted T cell receptor [J].
Berg, RE ;
Princiotta, MF ;
Irion, S ;
Moticka, JA ;
Dahl, KR ;
Staerz, UD .
IMMUNITY, 1999, 11 (01) :33-43
[7]   SELECTING THE T-CELL RECEPTOR REPERTOIRE [J].
BEVAN, MJ ;
HOGQUIST, KA ;
JAMESON, SC .
SCIENCE, 1994, 264 (5160) :796-797
[8]   RADIATION CHIMAERA, HOST H-2 ANTIGENS DETERMINE IMMUNE RESPONSIVENESS OF DONOR CYTOTOXIC CELLS [J].
BEVAN, MJ .
NATURE, 1977, 269 (5627) :417-418
[9]  
BRUCE J, 1981, J IMMUNOL, V127, P2496
[10]   Agonist peptide modulates T cell selection thresholds through qualitative and quantitative shifts in CD8 co-receptor expression [J].
Chidgey, A ;
Boyd, R .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) :1527-1536